Literature DB >> 21957291

In vitro generation of high-titer prions.

Ronald A Shikiya1, Jason C Bartz.   

Abstract

Prions are composed mainly, if not entirely, of PrP(Sc), an infectious misfolded isoform of PrP(C), the normal isoform of the prion protein. Here we show that protein misfolding cyclic amplification (PMCA)-generated hypertransmissible mink encephalopathy (HY TME) PrP(Sc) is highly infectious and has a titer that is similar, if not identical, to that associated with brain tissue from animals infected with the HY TME agent that are in the terminal stage of disease. These data demonstrate that PMCA efficiently replicates the prion agent and provide further support for the hypothesis that in vitro-generated prions are bona fide and are not due to contamination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21957291      PMCID: PMC3233131          DOI: 10.1128/JVI.06134-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Chronic wasting disease.

Authors:  Christina J Sigurdson; Adriano Aguzzi
Journal:  Biochim Biophys Acta       Date:  2006-10-18

2.  Modification of the pathogenesis of scrapie in mice by treatment of the agent.

Authors:  A G Dickinson; H Fraser
Journal:  Nature       Date:  1969-05-31       Impact factor: 49.962

3.  Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models.

Authors:  Qingzhong Kong; Shenghai Huang; Wenquan Zou; Difernando Vanegas; Meiling Wang; Di Wu; Jue Yuan; Mengjie Zheng; Hua Bai; Huayun Deng; Ken Chen; Allen L Jenny; Katherine O'Rourke; Ermias D Belay; Lawrence B Schonberger; Robert B Petersen; Man-Sun Sy; Shu G Chen; Pierluigi Gambetti
Journal:  J Neurosci       Date:  2005-08-31       Impact factor: 6.167

4.  Determination of scrapie agent titer from incubation period measurements in hamsters.

Authors:  S B Prusiner; S P Cochran; D E Downey; D F Groth
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

5.  Altered scrapie infectivity estimates by titration and incubation period in the presence of detergents.

Authors:  R A Somerville; R I Carp
Journal:  J Gen Virol       Date:  1983-09       Impact factor: 3.891

6.  Exposure to autoclaving or sodium hydroxide extends the dose-response curve of the 263K strain of scrapie agent in hamsters.

Authors:  D M Taylor; K Fernie
Journal:  J Gen Virol       Date:  1996-04       Impact factor: 3.891

7.  The nasal cavity is a route for prion infection in hamsters.

Authors:  Anthony E Kincaid; Jason C Bartz
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

8.  Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters.

Authors:  R A Bessen; R F Marsh
Journal:  J Gen Virol       Date:  1992-02       Impact factor: 3.891

9.  Synthetic mammalian prions.

Authors:  Giuseppe Legname; Ilia V Baskakov; Hoang-Oanh B Nguyen; Detlev Riesner; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

10.  Susceptibilities of nonhuman primates to chronic wasting disease.

Authors:  Brent Race; Kimberly D Meade-White; Michae W Miller; Kent D Barbian; Richard Rubenstein; Giuseppe LaFauci; Larisa Cervenakova; Cynthia Favara; Donald Gardner; Dan Long; Michael Parnell; James Striebel; Suzette A Priola; Anne Ward; Elizabeth S Williams; Richard Race; Bruce Chesebro
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more
  19 in total

1.  Cofactor molecules induce structural transformation during infectious prion formation.

Authors:  Michael B Miller; Daphne W Wang; Fei Wang; Geoffrey P Noble; Jiyan Ma; Virgil L Woods; Sheng Li; Surachai Supattapone
Journal:  Structure       Date:  2013-10-10       Impact factor: 5.006

2.  Protein misfolding cyclic amplification of prions.

Authors:  Samuel E Saunders; Jason C Bartz; Ronald A Shikiya
Journal:  J Vis Exp       Date:  2012-11-07       Impact factor: 1.355

3.  Selective amplification of classical and atypical prions using modified protein misfolding cyclic amplification.

Authors:  Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2012-11-20       Impact factor: 5.157

4.  Peroxymonosulfate Rapidly Inactivates the Disease-Associated Prion Protein.

Authors:  Alexandra R Chesney; Clarissa J Booth; Christopher B Lietz; Lingjun Li; Joel A Pedersen
Journal:  Environ Sci Technol       Date:  2016-06-20       Impact factor: 9.028

5.  PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.

Authors:  Karen E Marshall; Andrew Hughson; Sarah Vascellari; Suzette A Priola; Akikazu Sakudo; Takashi Onodera; Gerald S Baron
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

Review 6.  Prion strains: shining new light on old concepts.

Authors:  Alyssa J Block; Jason C Bartz
Journal:  Cell Tissue Res       Date:  2022-07-07       Impact factor: 5.249

7.  Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.

Authors:  Ronald A Shikiya; Thomas E Eckland; Alan J Young; Jason C Bartz
Journal:  Prion       Date:  2014       Impact factor: 3.931

8.  Isolation of novel synthetic prion strains by amplification in transgenic mice coexpressing wild-type and anchorless prion proteins.

Authors:  Gregory J Raymond; Brent Race; Jason R Hollister; Danielle K Offerdahl; Roger A Moore; Ravindra Kodali; Lynne D Raymond; Andrew G Hughson; Rebecca Rosenke; Dan Long; David W Dorward; Gerald S Baron
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

Review 9.  Environmental and host factors that contribute to prion strain evolution.

Authors:  Jason C Bartz
Journal:  Acta Neuropathol       Date:  2021-04-25       Impact factor: 17.088

10.  Chronic wasting disease in bank voles: characterisation of the shortest incubation time model for prion diseases.

Authors:  Michele Angelo Di Bari; Romolo Nonno; Joaquín Castilla; Claudia D'Agostino; Laura Pirisinu; Geraldina Riccardi; Michela Conte; Juergen Richt; Robert Kunkle; Jan Langeveld; Gabriele Vaccari; Umberto Agrimi
Journal:  PLoS Pathog       Date:  2013-03-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.